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Abstract . Brefeldin A (BFA) has a dramatic effect on
the morphology of the Golgi apparatus and induces
a rapid redistribution of Golgi proteins into the ER
(Lippincott-Schwartz, J., L . C . Yuan, J. S . Bonifacino,
and R . D. Klausner. 1989. Cell. 56:801-813) . To date,
no evidence that BFA affects the morphology of the
trans-Golgi network (TGN) has been presented . We
describe the results of experiments, using a polyclonal
antiserum to a TGN specific integral membrane pro-
tein (TGN38) (Luzio, J . P ., B. Brake, G. Banting,
K . E . Howell, P Braghetta, and K . K . Stanley. 1990.
Biochem. J. 270:97-102), which demonstrate that in-
cubation of cells with BFA does induce morphological
changes to the TGN . However, rather than redistrib-
xE last Golgi-associated compartment through which
secretory proteins pass before reaching their final des-
tination has been termed the trans-Golgi network
(TGN)' (Griffiths and Simons, 1986) . One of the unique
functions of the TGN is to package proteins into different
types of transport vesicles which can be directed either to a
pre-lysosomal/lysosomal compartment, dense-core secre-
tory granules or different domains ofthe plasma membrane
(Farquhar, 1985 ; Griffiths and Simons, 1986) . It also partici-
pates in retrieval and re-utilization of plasma membrane
componentsinternalized by endocytosis suchas the mannose-
6-phosphate and transferrinreceptors (Duncan and Kornfeld,
1988 ; DeBrabander et al., 1988) . The morphological attri-
butes ofthis compartment reflect these specialized functions .
Non-coated vesicles deliver constitutively secreted and in-
tegral membraneproteinsto the plasmamembrane. Clathrin-
coated buds are involved in packaging lysosomal and regu-
lated secretory proteins (Tooze and Tooze, 1986 ; Orci et al .,
1987; Robinson, 1990) . These buds are associated only with
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uting to the ER, the majority of the TGN collapses
around the microtubule organizing center (MTOC) .
The effect of BFA upon the TGN is (a) independent of
protein synthesis, (b) fully reversible, (c) microtubule
dependent (as shown in nocodazole-treated cells), and
(d) relies upon the hydrolysis of GTP (as shown by
performing experiments in the presence of GTPyS) .
ATP depletion reduces the ability of BFA to induce a
redistribution of Golgi proteins into the ER ; however,
it has no effect upon the BFA-induced relocalization of
the TGN . These data confirm that the TGN is an or-
ganelle which is independent of the Golgi, and suggest
a dynamic interaction between the TGN and microtu-
bules which is centered around the MTOC .
theTGN whereas non-clathrin-coated buds and vesicles are
found in the other Golgi cisternae (Orci et al., 1986 ; Mal-
hotra et al ., 1989) . The identification and description of this
compartment has been facilitated by use of cells infected
with vesicular stomatitis virus (VSV) in which protein ex-
port from the TGN is blocked by incubation of cells at 20°C
(Matlin and Simons, 1983 ; Griffiths and Simons, 1986) .
Quantitative studies have demonstrated that N12Î of the
TGN in these cells is made up of flattened cisternae whereas
the rest has a tubular-vesicular structure (Grifflths et al .,
1989) . The enzyme responsible for addition of the terminal
residues on N-linked carbohydrate moieties, sialytransferase,
has been localized primarily to the TGN (Farquhar, 1985)
although there are also reports of its distribution throughout
the rest of the Golgi stacks (Bretz et al., 1980) .
Immunocytochemical and biochemical experiments have
shown that the fungal metabolite BrefeldinA (BFA) inhibits
protein secretion in eukaryotic cells (Misumi et al., 1986),
and causes the redistribution of cis-, medial-, and trans-
Golgi markers into the ER (Doms et al ., 1989 ; Lippincott-
Schwartz et al ., 1990) . This redistribution is due to the inhi-
bition of anterograde vesicular transport from theER to the
Golgi and between Golgi stacks combined with the concomi-
tant formation ofan extensive tubular network that connects
previously separate cisternae (Lippincott-Schwartz et al.,
1990 ; Orci et al ., 1991) . The end result is the mixing ofER
85and Golgi proteins. This effect has been shown to be specific
as well as energy, GTP, and microtubule dependent (Lippin-
cott-Schwartz et al., 1990; Donaldson et al., 1990) . Sev-
eral lines of evidence suggest that, although the trans-Golgi
cisternae redistribute into the ER, the TGN does not. Im-
munolocalization experimentsusing antibodies to galactosyl-
transferase, a trans-Golgi marker, demonstrated the redistri-
bution of this enzyme into the ER following BFA treatment
(Lippincott-Schwartz et al., 1990) . Additional evidence for
the redistribution of galactosyltransferase has been derived
from experiments in which mannose-6-phosphate receptors
acquired N-linked galactose in the ER of BFA-treated cells
(Chege and Pfeffer, 1990). In contrast, recently published
data have been interpreted to mean that the TGN does not
redistribute following treatment of cells with BFA. Most
analyses of the effects of BFA on the TGN have been based
on functional assays assessing the ability of sialyltransferases
to sialylate proteins trapped in the ER aftertreatment. These
experiments showed that neuraminidase digestion failed to
alter the molecular weight of VSVG protein extracted from
BFAtreated cells, indicating that there was no addition ofthe
terminal sialic acid residues normally acquired by this pro-
tein in the TGN (Doms et al., 1989) . IfBFA induced redistri-
bution of the TGN into the ER had occurred, then one would
have expected the VSVG protein to have been sialylated.
Chege and Pfeffer (1990) showed that newly synthesized
mannose-6-phosphate receptors do not acquire sialic acid af-
ter BFA treatment (as judged by their inability to bind to a
sialic acid-specific lectin); however, cell surface receptors
were partially sialylated afterendocytosis. The results ofim-
munolocalization experiments using wheat germ agglutinin
(WGA) and a TGN-specific mAb have also been interpreted
as indicating that the TGN does not redistribute following
BFA treatment of cells (Lippincott-Schwartz et al ., 1990) .
To investigate the effects of BFA on the morphology of
the TGN we have taken an immunocytochemical approach,
using antibodiesto an integral membrane proteinofthe TGN,
TGN38. The cDNA encoding TGN38 was isolated using a
polyclonal antiserum raised against a detergent-extracted
Golgi membrane fraction (Luzio et al., 1990). Immunogold
EM using anti-TGN38 antibodies showed staining only on
the trans face of the Golgi complex in thin frozen sections.
In cellsinfected with VSV and incubated at 20°C before fixa-
tion, VSVG protein and TGN38 colocalized to the TGN. In
this report we demonstrate a rapid and reversible redistribu-
tion of TGN38 upon BFA treatment and have characterized
this effect in termsof its energy requirement and dependence
on guanine nucleotides and microtubules.
Materials andMethods
Materials
BFA was purchased from Cambio (Cambridge, U.K.) and Epicentre Tech-
nologies (Madison, Wisconsin), stored as a 5 mg/ml stock in methanol at
-20°C and used at a final concentration of 5 Ieg/mi in culture medium.
Nocodazole, cycloheximide, and 2-deoxy-D-glucose were obtained from
Sigma Chemical Company (Poole, Dorset, UK.). The concentration of
nocodazole was 20 pg/ml in all incubations and was kept as a 10 mg/ml
stock in DMSO at -20°C. Cycloheximide (freshly prepared) was used at
final concentration of 10 gg/ml. GTRyS was purchased from Boehringer
Mannheim U.K. (Lewes, East Sussex, U.K.) and used at a final concentra-
tion of 1 mM.
The Journal of Cell Biology, Volume 116, 1992
Antibodies
The rabbit anti-rat TGN38 polyclonal antiserum has been described previ-
ously (Luzio et al., 1990). The anti-mannosidase II mAb (Burke et al.,
1982; Baron andGaroff, 1990) wasthe kindgift ofDr. GrahamWarren (Im-
perial Cancer Research Fund, London) andthe monoclonal anti-lysosomal
antibody was generously provided by Dr. Dan Cutler (Imperial College,
London). The anti-tubulin antibody was purchased from Serotec (Kidling-
ton, Oxford, U.K.). Fluorescein-labeled goat anti-rabbit IgG and fluores-
cein- and rhodantine-labeled goat anti-mouse IgG were obtained from
Sigma Chemical Company. Rhodamine-labeled swine anti-rabbit IgG was
from Dako (High Wycombe, Bucks., UK.).
Cell CultureandImmunofluorescence Microscopy
Normal ratkidneycells weregrownin McCoy's medium (GIBCO, LifeTech-
nologies Ltd., Paisley, Scotland) supplemented with 10% FCS (GIBCO,
LifeTechnologiesLtd.), 2 mM glutamine (GIBCO, Life Technologies Ltd.),
100 pg/ml streptomycin (Evans Medical Ltd., Langhurst, Horsham, En-
gland), and 60 pg/ml penicillin (Glaxo Laboratories Ltd., Greenford, En-
gland) at 37°C in 5% C02. Cells were plated onto 22-mm glass coverslips
24-48 h before use (-60-70% confluency). After the appropriate drug
treatments, cells were washed threetimes with PBS andthen fixed and per-
meabilized by incubation in methanol at -20°C for 5 min. The coverslips
were then incubated in PBS/0.2% BSA for 5 min followed by a PBS wash
and incubation with primary antibody in PBS/0.2% BSA for 1 h at room
temperature. After washing (4 x 2 m1s) in PBS/0.2 % BSAtoremove excess
primary antibody, the cells were incubated at room temperature with
fluorescently-labeled secondary antibody for 30 min, washed, and mounted
in Mowiol (Calbiochem, San Diego, CA). Epifluorescence microscopy was
performed on a Universal microscope (Zeiss, Oberkochen, Germany) with
a 63x, 1.4 oil immersion objective.
CellPermeabilization
Cells grown on coverslips were permeabilized by filter stripping with
nitrocellulose according to the method of Simons and Virta (1987) and as
described by Donaldson et al. (1990). Briefly, a pre-soaked nitrocellulose
filter (Millipore Continental Water Systems, Bedford, MA) was overlaid on
top of subconfluent NRK cells on coverslips for 1 min, and then gently
peeled off. Cells were then prepared for immunofluorescence microscopy
as described above.
Results
EffectsofBFA on theSubcellularLocalization
ofTGN38
Previous immunocytochemical studies at the light and EM
level have shown the disappearance of the Golgi cisternae
upon BFA treatment and concomitant appearance of secre-
tory proteins diffusely spread throughout the ER (Fujiwara
et al., 1988) . To determine the fate of the TGN after similar
treatment we treated NRK cells with 5 jg/ml BFA for 3 h
at 37°C and examined the subcellular localization of TGN38
by inununofluorescence microscopy (as described in Mate-
rialsandMethods). As shown in Fig. 1 a, the pattern ofstain-
ing in control cells reveals a typical perinuclear cap which
is punctate in appearance and has been reported previously
(Luzio et al., 1990). There is an absence of staining of the
plasma membrane, cytosol, and more distal portions of the
cell. After 3 hofBFA treatment, however, thepattern ofstain-
ing reveals a concentration of TGN38 in the majority of cells
in one distinct perinuclear spot (Fig. 1 b). In addition, there
is a diffuse staining of the cytoplasm which consequently
enables the visualization ofthe entire cell as opposed to just
the perinuclear staining seen in control cells. Confocal mi-
croscopy allowed sampling ofdifferent planes ofthe cell and
revealedthatthis diffusepattern ofstainingoccurred through-
out the entire cytoplasm (data not shown).
86Mannosidase II, a marker of the medial-Golgi compart-
ment, has been shown by immunofluorescence and immuno-
electron microscopy to redistribute into the ER upon BFA
treatmentofcells (Lippincott-Schwartz etal ., 1989) . Experi-
ments assessing the uptake and degradation of 1151-asialofe-
tuin in the presence ofBFA suggested that the drug does not
affect the endocytic or lysosomal pathways (Misumi et al.,
1986) . We have used antibodies to mannosidase II and to the
lysosomal compartment to confirm that the redistribution of
TGN38 is a specific effect on theTUN . In control cells, anti-
bodies to mannosidase II exhibit a pattern of staining similar
to that seen with anti-TGN38 antibodies, i.e ., a distinct peri-
nuclear localization (Fig . 1 c) . As expected, in BFA-treated
cells the anti-mannosidase II antibodies exhibit a dispersed
pattern of staining throughout the cytoplasm (Fig . 1 d) . The
anti-mannosidase II antibodies do not give the concentration
ofjuxtanuclear staining seen with anti-TGN38 antibodies on
BFA-treated cells (compare Fig . 1, b and d) . Anti-lysosomal
antibodies revealed an evenly dispersed punctate distribution
about the nucleus in the presence or absence of BFA (Fig .
1, e and f) .
MicrotubuleDependence ofBFA-induced
TGN Redistribution
The Golgi apparatus is situated at the minus ends of inter-
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Figure 1. Effect of BFA on
the subcellular localization of
TGN38. Methanol-fixed NRK
cells were incubated with differ-
entantibodiesinthepresence(b,
d, and f) or absence (a, c, and
e) of BFA . Anti-TGN38 anti-
body (a and b), anti-mannosi-
dase II antibody (c and d), and
anti-lysosomal antibody (e and
f) . Bar, 10 ,m .
phase microtubules at the site ofmicrotubule nucleation, the
microtubule-organizing center(MTOC) (Kreis, 1990 ; Kelly,
1990) . The majority ofcells treated with BFA, and immuno-
stained for the presence ofTGN38, contained only one area
ofconcentrated immunofluorescence . However, in a minority
ofcells two areas were present (Fig . 1 b) . These two patterns
offluorescence are reminiscent ofthose seen with interphase
and mitotic cells stained with and-MTOC antibodies (Rout
and Kilmartin, 1990) . To test whether there was any colocal-
ization ofTGN38 and the MTOC after BFA treatment, cells
were double stained with anti-tubulin and anti-TGN38 anti-
bodies . As shown in Fig . 2 (a and c), the arrays of tubulin
emanate from a single juxtanuclear point corresponding to
the MTOC. In control cells the TGN staining spreads out
from the same point (Fig . 2 b), while in BFA-treated cells
the juxtanuclear concentration of fluorescence colocalizes
with the center of the tubulin array (compare Fig . 2, c and
d) . This colocalization suggests that, in the presence of BFA,
the TGN is concentrated at the MTOC .
BFA-induced Redistribution ofTGN38 is Multi-Phasic
and Independent ofProtein Synthesis
In BFA-treated cells, TGN38 can be seen in two distinct sub-
cellular regions : a tight perinuclear concentration at the
MTOC and diffusely throughout the cell . To assess the ki-netics of redistribution of these two components we treated
cellswith 5,ug/mlBFAforvaryingtimesbefore immunofluo-
rescence analysis using anti-TUN38 antibody. There were no
obvious changes in subcellular distribution of the TGN at
early time points (<1 min, Fig . 3, b and c) . In cells treated
withBFA for 5 minstaining of theTGN appearedmore dif-
fuse than in control cells, but still somewhat punctate, with
projections emanating outward from the typical perinuclear
cap (Fig. 3d) . In cells whichhad been treated with BFA for
10minarapid reversal ofthis apparent dispersal processhad
occurred, and a compact center ofTGN38 staining hadbe-
gun to appear at thenuclearmembrane (Fig . 3 e) . Cells incu-
bated in thepresence ofBFAfor30min before immunofluo-
rescence analysis using anti-TGN38 antibody demonstrated
aclear perinuclear localization oftheTUN; the diffuse stain-
ingofthe cytoplasmwasalso apparent (Fig . 3g) . The distri-
bution of theTGN seen in cells treated withBFA for 30 min
had stabilized in cells treated with BFA for 1-3 h (Fig. 3, h
and i) . This time course was repeated multiple times with
similar results.
Immunofluorescence analysis, usinganti-TGN38 antibody,
was also performedon cellswhich hadbeen pre-treated with
201&g/ml cycloheximide for 1.5 hbefore a 3-h incubation in
BFA . This was to determine whether (a) the diffuse pattern
of staining seen throughout the cell followingBFAtreatment
is because ofdispersal ofnewlysynthesizedTGN38 from the
cis-, medial-, and trans-Golgi cisternae into the ER and (b)
whether any part of the BFAinduced redistribution of the
TUN is dependenton protein synthesis. Cycloheximide treat-
ment had no observable effect onBFAinduced redistribution
of theTGN (data not shown) .
BFA-induced Redistribution ofTGN38 is Reversible
Cellsgrownon coverslips were incubated at 37°C in the pres-
ence of 5 Wg/ml BFA for 3 h, washed, and then incubated at
37°Cin theabsenceofBFAforvaryingtimesbefore immuno-
fluorescence analysis using anti-TGN38 antibody. Within
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Figure 2 . Colocalization of
redistributed TGN with the
MTOC . Methanol fixedNRK
cellswere incubatedwith mu-
rine monoclonal anti-tubulin
antibodies and rabbitpolyclonal
antiseratoTGN38 in thepres-
ence (panels c and d) or ab-
sence (panels a and b) of
BFA. Binding of anti-tubulin
antibody was detected using
rhodamine conjugated sec-
ondantibody (b andd), bind-
ing of antiTGN38 antibody
using fluorescein conjugated
second antibody (a and c) .
Bar, 10 gym .
5 min of removal of BFA from the incubation medium an
elongation of the tight juxtanuclear patternofTUN staining
wasobserved, the first step in thereversal ofits redistribution
(Fig . 4a) .ThemovementoftheTGNback to its original peri-
nuclear position proceeded through a stage similar to that
seen in cells which had been incubated in the presence of
BFA for5-10 min, however it was sightly slower (15 min in
the absence of BFA) in reaching this distribution pattern
(Fig. 4b) . Recovery was complete following a 1-h incubation
at 37°C in the absence of BFA (Fig. 4 d) . By this time, the
immunofluorescence staining pattern seen with antiTGN38
antibodies closely resembled that observed in control cells .
Effect ofNocodazole on BFA-induced Redistribution
ofthe TGN
In studiesusing microtubule disrupting agents (Rogalskiand
Singer, 1984) and in studies on mitotic cells (Lucocq and
Warren, 1987), it has been shown that the localization of the
Golgi complex is perturbed when the microtubule network
is dissociated . The retrograde transport of proteins from the
Golgi stack to the ER has also been shown to be dependent
on microtubules (Lippincott-Schwartz et al ., 1990) . The lo-
cation of TGN38 in BFAtreated cells, in a tight concentra-
tion next to the nucleus, suggested that the TGN might be
collapsing toward theMTOC during thecourse ofBFA treat-
ment . We used the ability of nocodazole to inhibit tubulin
polymerization (DeBrabander et al ., 1976)to assess whether
microtubules are necessary for this redistribution to occur.
Cells were treated with different combinations of BFA and
nocodazole, fixed, permeabilized, and processed for im-
munofluorescence analysis using anti-TGN38 antibody. In
cells whichhadbeen treatedwith nocodazole alone, the pat-
tern of staining suggested a fragmentation of theTGN into
tightvesicular structures dispersed throughout thecytoplasm
(Fig . 5 b) . A similar pattern has been observed when anti-
bodies to other Golgi proteins have been used in inununo-
fluorescence analysisofnocodazole-treated cells (Lippincott-Schwartz et al ., 1990) . Cells pre-treatedwith nocodazole for
2 h before addition ofBFA for 1 h lack the tight perinuclear
dot seen in cells incubated with BFA alone (compare Fig. 5,
c with a) . However, small vesicular structures are stained
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Figure 3 Time course ofBFA
induced redistribution of the
TUN . NRK cells were incu-
bated at 37°C in the presence
of 5 jAg1ml BFA for the indi-
cated times before processing
for immunofluorescence anal-
ysis using antiTGN38 anti-
body (a = 0 min, b = 0.5
min, c = 1 min, d = 5 min,
e = 10 min, f = 15 min, g =
30 min, h = 60 min, i = 180
min) . Bar, 10 jm .
throughout most of the cell and there is very diffuse staining
ofthe entire cytoplasm (Fig . 5 c) . Cells treated with BFA for
1 h before nocodazole treatment for 2 h also contain punctate
vesicular structures in addition to the diffuse cytoplasmic
89staining ; however, these vesicles are concentrated in a peri-
nuclear region rather than being dispersed throughout the
cell (Fig. 5 d) . These results support the hypothesis that mi-
crotubules are essential for both (a) the initial collapse of the
TGN towards the nucleus and (b) maintaining this position
once attained .
Energy RequirementforBFA-inducedRedistribution
of theTUN
To determine whetherTGN redistribution was energy depen-
dentwe lowered cellularATP levels by incubatingNRK cells
with 50mM 2-deoxy-D-glucose and 3mM sodium azide for
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3 min at 37°C before addition of 5 /Ag/ml BFA . Cells were
then incubated at 37°C for a further 30 min before process-
ing for immunofluorescence analysis (Lippincott-Schwartz
et al ., 1989) . ATP depletion inhibited the BFAinduced re-
distribution of mannosidase II (Fig. 6, b and c) (Lippincott-
Schwartz et al ., 1989) . However, it had no effect on the BFA
induced redistribution of TGN38 (Fig . 6, e and f) . This
result demonstrates that the effect ofBFA on theTGN is less
sensitive toenergy-depletion protocols thanthe BFA-induced
redistribution of mannosidase II to the ER . Similar results
were obtained using the anti-TGN38 antibody and a more
stringentprotocol for reducing ATP levels . This consisted of
90
Figure 4 . NRK cells were in-
cubated at 37°C in the pres-
ence of 5 pg/mlBFA for 3 h,
then at 37°C in the absence of
BFA for 5 min (a), 15 min (b),
30 min (c), or 60 min (d)
before processing for immu-
nofluorescence analysis using
anti-TGN38 antibody . Bar,
10 ,,m .
Figure 5 . NRK cells were sub-
jected to the following treat-
ments before processing for
immunofluorescence analysis
using anti-TGN38 antibody.
Incubation for 2 h at 37°C in
the presence (b) or absence
(a) of 20 Aglml nocodazole
alone, or in the presence of 20
Aglml nocodazole for 2 h fol-
lowed by 5 ug/ml BFA for 1 h
(c), or in the presence of
5 AglmlBFA for 1 h followed
by 20 wg/ml nocodazole for
2 h (d) . Bar, 10 lm .treating cells with 1mM 2-deoxy-n-glucose and 10mM so-
dium azide for 30min in serum-freemedium at 37°C (Thmer
and Tartakoff, 1989) before incubation with BFA for an addi-
tional 30 min (data not shown) .
GTPRequirementfor MA-induced Redistribution
of theTGN
GTP has been shown to be involved in the uncoating of non-
clathrin-coated Golgi vesicles (Melancon et al., 1987) and
has been implicated in the regulation of the association and
disassociation of a peripheral membrane protein, ß-COP,
from the Golgi stacks (Donaldson et al., 1990) . A-COP has
been localized not only to the transitional elements and the
Golgi stacks but also to the TGN (Duden et al ., 1991) . To
test whether any component ofthe redistribution oftheTGN
is GTP dependent we permeabilized cells grown on cover-
slips by filter stripping with nitrocellulose according to the
method of Simons and Virta (1987) and as described by
Donaldson et al . (1990) . Before processing for immunofluo-
rescence analysis with anti-TGN38 antibody, the permeabi-
lizedcells were incubated at 37°C for 1 h under the following
conditions : (a) with incubationbuffer alone, (b) with incuba-
tion buffer plus 5 pg/ml BFA, (c) with incubation buffer plus
1 mM GTPyS, or (d) with incubation buffer plus 1 mM
GTPyS followed by addition ofBFA to 5 pg/ml and incuba-
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Figure 6 . NRK cells were sub-
jected to the following treat-
ments before processing for
immunofluorescence analysis
using anti-Mannosidase II an-
tibody (a-c) or anti-TGN38
antibody (df) . Incubation for
3 min at 37°C in the presence
(b and e) or absence (a and d)
of 50 mM 2-deoxy-n-glucose
and 3 mM sodium azide
alone ; incubation for 3 min at
37°C in the presence of 50
mM 2-deoxy-n-glucose and
3 mM sodium azide followed
by 30 min at 37°C in the pres-
ence of5 14g/mlBFA (c andf) .
Bar, 10 Km.
tion for a further 1 h at 37°C . There was no difference in the
pattern ofTGN38 staining between non-permeabilized cells
and permeabilized cells incubated in buffer alone or in buffer
plus GTPyS (compare Figs. 6 a and 7, a and c) . BFA treat-
ment had the same effect on permeabilized cells as it did on
intact cells (compare Fig. 7 b and 6 b) . However, in per-
meabilized cells incubated with GTPyS prior to BFA treat-
ment the pattern ofTGN38 staining is reminiscent of that
seen in non-BFAtreated cells (compare Fig . 7, a and d) .
This result implies that hydrolysis ofGTP is required during
the BFAinduced redistribution of the TGN .
The data presented demonstrate thatBFA induces a redistri-
bution of the TGN in NRK cells . The initial effects ofBFA
are fairly rapid, with observable alterations to the morphol-
ogy oftheTGN within 5minofaddition ofthe drug. Approx-
imately 1 h after addition ofBFA the TGN has stabilized in
its new position, predominantly juxtanuclear (colocalized
with the MTOC), but with significant amounts distributed
throughout the cell . Previous work has shown that the BFA-
induced redistribution of components of the Golgi stack to
the ER is energy, GTP, and microtubule dependent as well
as being reversible (Lippincott-Schwartz et al ., 1989 ; Lippin-
cott-Schwartz et al ., 1990 ; Don aldson et al ., 1990 ; Donald-son et al ., 1991) . We have characterized BFA-induced redis-
tributionoftheTGN with respectto each ofthese parameters,
and found that it too is GTP and microtubule dependent as
well as being reversible. Significantly, however,BFAinduced
redistribution of the TGN is not energy dependent .
EM studies have shown that the cisternal Golgi stacks dis-
appear following BFA treatment of cells (Misumi et al .,
1986 ; Fujiwara et al ., 1988 ; Lippincott-Schwartz et al .,
1989) . This disappearance of the Golgi stacks is paralleled
by the appearance of clusters of small vesicles associated
with the centrioles . The number of vesicles observed is in-
sufficient to account for all the membrane previously found
in' the Golgi cisternae (Ulmer and Palade, 1989) . Recent
work would suggest that, in BFAtreated cells, the major-
ity of Golgi-derived membrane would not be in vesicular
structures but colinear with the ER membrane (Lippincott-
Schwartz et al ., 1989 ; Orci et al ., 1991) . In light of the data
we have presented, it is probable that the clusters of small,
centriole-associated vesicles observed in BFA-treated cells
by Ulmer and Palade (1989) are derived from the TGN .
Previous studies to have addressed the question ofwhether
BFA treatment affects the TGN have assayed the degree of
sialylation ofproteins trapped in the ER after collapse of the
cis-, medial- and trans-Golgi compartments into the ER . In
BFA-treated cells, VSVG protein became endoglycosidase
H resistant . This indicated that it had been processed by en-
zymes, normally resident in cis- andmedial-Golgi cisternae,
which had redistributed to the ER . Addition of sialic acid to
VSVG protein did not occur, implying that the contents of
the TGN had not been affected in the same way as those of
the cis- and medial-Golgi cisternae (Doms et al ., 1989) . Ad-
dition ofsialic acid to hemagglutinin was markedly inhibited
in BFA-treated cells as was transport ofthe protein to the cell
surface (Nuchtern et al ., 1989) . Chege and Pfeffer (1990) re-
ported that, in cells incubated inBFA for 8 h, <10% of man-
nose-6-phosphate receptors acquired sialic acid . In these ex-
periments some sialylation of receptors recycled from the
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Figure 7 . Filter-strippedNRK
cells were subjected to the
following treatments before
processing for immunofluo-
rescence analysis using anti-
TGN38 antibody. Incubation
for 1 h in incubation buffer
(a), incubation for 1 h at 37°C
in incubation buffer plus 5 ug/
mlBFA (b), incubation for 1 h
at 37°C in incubation buffer
plus 1 mM GTPyS (c), incu-
bation for 1 h at 37°C in in-
cubation buffer plus 1 mM
GTP,yS followed by incuba-
tion for 1 h at 37°C in incuba-
tion buffer plus 5 ug/ml BFA
(d) . Bar, 10 um .
cell surface was detected . By contrast, inBFA-treatedmurine
erythroleukemia cells, glycophorin was eventually sialylated
(as judged by its ability to bind WGA) (Ulmer and Palade,
1989) . It has been proposed that the slightly different results
obtained by the two groups may be due to different degrees
of disruption of the Golgi complex in the two cell types. It
has also been suggested that the sialylation of O-linked car-
bohydrate on glycophorin might be due to an enzyme which
is distinct from that required for the addition of sialic acid
residues to N-linked sugars on mannose-6-phosphate recep-
tors, and that this enzyme is normally located in either the
medial- or trans-Golgi cisternae rather than the T'GN (Chege
and Pfeffer, 1990) . Taken together these data suggest that
BFA does not cause redistribution of residentTGN enzymes
into the ER and that, even in the presence of BFA, it may
retain some ofits functions . They do not address the question
of whether or not BFA induces redistribution of the TGN to
sites other than the ER . Others have performed limited im-
munocytochemical studies using a TGN-specific mAb and
WGA as markers of the TGN (Lippincott-Schwartz et al.,
1989) . These experiments have been interpreted as showing
that the TGN is morphologically unaffected by BFA . How-
ever, whileWGA does bind the terminal N-acetylneuraminic
acid residues one would expect to find predominantly in the
TGN and thereafter in the secretory pathway (Tartakoff and
Vassalli, 1983), it also binds other carbohydrate structures
(Goldstein and Hayes, 1978), thus limiting its validity as a
specific marker of the TGN . The WGAassociated fluores-
cence staining presented by Lippincott-Schwartz et al . (1990)
is quite intense ; our data show that the distribution of the
TGN in control and BFA-treated cells is subtly different, the
intensity of the WGA-associated fluorescence may well have
masked this difference . Intensity of staining might also ex-
plainwhy themAb used by Lippincott-Schwartz et al . (1990)
failed to discriminate between the morphology of the TGN
in BFA treated and control cells . We have repeated our im-
munofluorescence assays using the fixation and permeabili-
92zation procedures used by Lippincott-Schwartz et al. (1990)
and obtained the same results as those presented inthispaper.
Disruption of microtubules by nocodazole ablates the
BFA-induced concentration ofTUN38 at the MTOC, but has
little effect on the diffuse cytoplasmic staining. The localiza-
tion and stability of the Golgi complex as a whole has been
shown to be microtubule dependent (reviewed in Kelly,
1990; Kreis, 1990). In addition it has been proposed that a
110-kD protein, / .COP, may play a role in linking Golgi
membranes to a "scaffold" or skeletal framework based on
microtubules which originate at the MTOC (Duden et al .,
1991). #-COP associates not only with the more proximal
Golgi stacks but also with the TGN and dissociates from
membranes within minutes of BFA treatment (Duden et al .,
1991; Donaldson et al., 1990). ß-COP may, therefore, also
be tethering the TGN to this scaffold. In vitro experiments
by Orci et al. (1991) have suggested that there is a dynamic
balance governing anterograde (vesicular) and retrograde
(tubular) transport between the Golgi stacks. This balance
is tipped in favor of retrograde transport in the presence of
BFA since the release of ß-COP from membranes inhibits
vesicle formation but does not affect the formation of retro-
grade tubules. The predominance of retrograde transport
rapidly redistributes components of late Golgi stacks into
early Golgi stacks, and eventually into the ER (Lippincott-
Schwartz et al., 1989) . The BFA-induced release of ß-COP
from the TGN membrane does not appear to result in the
same redistribution as that observed for the Golgi stacks
(Nuchtern et al., 1989; Chege and Pfeffer, 1990; and this pa-
per). This would imply thatthe balance between anterograde
and retrograde transport found between the Golgi cisternae
is not found between the Golgi and the TGN and suggests a
lack of tubular retrograde transport from the TGN to the
trans-Golgi. Thus, if fl-COP does anchor the TGN to a scaf-
fold,BFA treatment would dissociatethe TGN from that scaf-
fold and also from the Golgi stacks. This would allow the
TGN to migrate to the MTOC rather than redistributing into
the ER, and is the effect we have observed. The initial distri-
bution ofthe TUN towards the ER may be due to a difference
in kinetics between uncouplingofthe TGN from the scaffold
and uncoupling from the rest of the cisternae.
GTPyS has been shown to block vesicular transport be-
tween the Golgi stacks by inhibiting vesicle uncoating; this
leads to an accumulation of non-clathrin-coated vesicles
(Melancon et al., 1987; Orci et al., 1989) . Duden et al.
(1991) demonstrated that this effect of GTPyS is correlated
with an increase in the amount of ß-COP associated with
non-clathrin-coated vesicles, implying that GTP hydrolysis
is required to release ß-COP from the coat as a prerequisite
ofvesicle uncoating. Pretreatment of cells with GTPyS pre-
vents both the BFA-induced release of ß-COP from Golgi
membranes and the movement of Golgi membrane into the
ER (Donaldson et al., 1991) . By analogy with these findings,
one would expect (a) GTP hydrolysis to release ß-COP from
an interaction between a scaffold, ß-COP, and the TGN
membrane, thus leading to a redistribution of the TGN, and
(b) pretreatment with GTPyS to inhibit BFA-induced redis-
tribution of the TGN. Data presented in this paper are in ac-
cord with this model, since GTPyS alone has no effect on
the subcellular distribution of the TGN while pretreatment
ofcells with GTPyS prevents the BFA-induced redistribution
of the TGN.
Reaves and Banting BFADisrupts the Morphology ofthe TGN
The diffuse TGN38 staining seen throughoutthe cytoplasm
in BFA-treated cellsis reminiscent of the pattern of ER stain-
ing seen with anti-mannosidase II antibodies in BFA-treated
cells. This may indeed represent a BFA-induced redistribu-
tion to the ER of a proportion of the contents of the TGN and
might serve to explain the observation of Chege and Pfeffer
(1990) that there is some sialylation of mannose-6-phosphate
receptors in BFA-treated cells. However, two pieces of evi-
denceargue against this beingredistribution to the ER. Firstly,
the BFA-induced dispersal of mannosidase R into the ER
can be inhibited following depletion of ATP, whereas ATP
depletion has no effect on the BFA-induced redistribution of
TGN38. Secondly, mannosidase II appears throughout the
ER within 10 min of addition of BFA to cells (Lippincott-
Schwartz et al., 1990), whereas the diffuse pattern of TGN38
staining does not begin to appear until 15 min after addition
of BFA. The precise nature of the diffuse structures recog-
nized by anti-TGN38 antibodies in BFA-treated cells remains
unclear.
The TGN is morphologically distinct from the Golgi
cisternae in that it has more of a tubular-vesicular structure
(Grifflths et al., 1989) in keeping with its function as a sort-
ing site for proteins destined for different locations within the
cell. Other compartments with a similar configuration in-
clude the ER, the early endosomal network, and the tubular
lysosomes of macrophages. A number of studies have sug-
gested that the development oftubular extensions from these
compartments are microtubule dependent (Cooper et al .,
1990; Lee and Chen, 1988; Hollenbeck and Swanson,
1990) . Introduction of anti-kinesin antibodies into macro-
phages results in the centripetal collapse of the arrays of
tubular lysosomes into a perinuclear mass suggesting that
kinesin is responsible for maintaining the extensions of this
organelle (Hollenbeck and Swanson, 1990). If a similar situ-
ation exists for the TGN, and BFA not only inhibits the as-
sociation of ß-COP with membrane but also dissociates a
kinesin-like motor from the TUN, one would predict that
BFA treatment would result in the collapse of the TGN into
the cell center. This is what we have observed.
The morphology and subcellular localization of the TGN
are clearly affected by BFA in a manner which is both revers-
ible and microtubule and guanine nucleotide dependent. It
remains to be seen whether these effects are due solely to di-
rect interactions between BFA and ß-COP, or whether there
are also direct or indirect interactions between BFA and
kinesin-like motors.
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